Sun, 12 Jul 2020

According to a new market research study titled 'Vaccines Market - Global Analysis and Forecasts by Technology, Disease Indication, Route of Administration, and Patient Type. The global vaccines market is expected to reach US$ 64,538.4 Mn in 2027 from US$ 36,998.8 in 2018. The market is estimated to grow with a CAGR of 6.5% from 2019-2027.

Vaccines are biological preparation which help in enhancing the immunity system towards a disease. A vaccine contains an agent that is similar to a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. Based on the antigens being used, vaccines are available in various forms. Some of the common disease indications for which vaccines are available are, pneumococcal disease, DTP, influenza, HPV, polio and hepatitis, among others.

Vaccines Market to 2027 - A comprehensive research report created through extensive primary research (inputs from industry experts, companies, and stakeholders) and secondary research, the report aims to present the analysis of Global Vaccines Market By Technology, Disease Indication, Route of Administration, Patient Type and Geography- North America, Europe, South America, Asia-Pacific, Middle East and Africa. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global Vaccines market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Get Sample Copy at

The vaccines market is highly competitive in nature with considerable number of players, having a high level of consolidation overall revenue share. Most of the companies operating in the vaccines market are present globally and have wide distribution and sales network through partnerships or authorized dealers.

Most Notable Market Participants-


-GlaxoSmithKline plc.

-Merck & Co., Inc.


-Johnson & Johnson Services, Inc

-Panacea Biotec Limited

-Astellas Pharma Inc.


-VBI Vaccines Inc.

-Bavarian Nordic

Market leaders are involved in extensive research for the development of new vaccines and therapeutics with better efficiency and treatment outcomes. For instance, in December 2018, The U.S. Food and Drug Administration (FDA) has approved a combination "diphtheria-tetanus-pertussis-hepatitis B-poliomyelitis-invasive haemophilus influenza type B disease" vaccine developed by Merck and Sanofi in partnership.

The global vaccines market on the patient type is segmented into pediatric patients and adult patients. In 2018, the pediatric segment held a largest market share of 70.0% of the vaccines market, by patient type. This segment is also expected to dominate the market in 2027 as external immunization is necessary for the new borns. Moreover, vaccines have helped the children in staying healthy and been successful to save millions of lives for more than 50 years.

Get Detail Facts and Figures at


By Technology

-Recombinant vaccines

-Conjugate Vaccines

-Live Attenuated Vaccines

-Inactivated Vaccines

-Toxoid Vaccines

By Disease Indication

-DTP (diphtheria, tetanus, and pertussis)



-Respiratory Syncytial Virus (RSV)

-Other Diseases

By Route of Administration




-By Patient Type

-Adult Patients

-Pediatric Patients

By Geography

-North America










-Asia Pacific (APAC)





-South Korea

-Middle East & Africa (MEA)

-Saudi Arabia

-South Africa


-South America (SAM)



Buy this Study now at

About Us - The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

More Los Angeles News

Access More

Sign up for Los Angeles News

a daily newsletter full of things to discuss over drinks.and the great thing is that it's on the house!